PRNewsWire
30 Jun 2026, 11:43 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
A two-year real-world study of 2,470 patients showed that the kidneyintelX.dkd test led to sustained improvements in kidney function and a reduction in individual patient risk trajectories. — Positive long-term clinical data for an FDA-approved product typically drives adoption and increases the commercial valuation of the medical diagnostics provider.
+0.60The study demonstrated that nearly one-third of high-risk patients moved to a lower risk category after one year following the initiation of therapy guided by the test. — Quantifiable evidence of treatment efficacy linked to the diagnostic tool provides a strong value proposition for health systems and insurers.
+0.40Renalytix's kidneyintelX.dkd test has already received FDA approval and Medicare reimbursement for commercial use in the United States. — Medicare reimbursement removes a primary barrier to scaling revenue, providing a stable financial foundation for the product's growth.
+0.30Continue reading
6 related stories
Top 1 mover · tap to explore
Which stocks this story touches
The company announced highly positive two-year real-world evidence results for its FDA-approved KidneyIntelX test, demonstrating sustained improvements in kidney function.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
54m ago
